| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | General Counsel
1 company
Walker Marlan D is a Chief Executive Officer at TXMD. Recent filings cover 3 purchases and 5 sales. Those positions are worth an estimated $74K at current prices.
Our model assigns Walker Marlan D a strong insider score of 81/100, based on 8 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +72.8%.
Walker Marlan D's largest disclosed position is in TXMD as Chief Executive Officer, worth about $74K. The recent filings there lean toward selling, a net 40,067 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2025 | TXMD Therapeuticsmd, Inc. | Chief Executive Officer | Buy | 490 | $1.00 | $489.27 | +0.7% | +13.6% | +101.0% | |
| Apr 10, 2025 | TXMD Therapeuticsmd, Inc. | Chief Executive Officer | Buy | 2,303 | $0.87 | $1,994.01 | +3.3% | +39.3% | +136.3% | |
| Dec 7, 2023 | TXMD Therapeuticsmd, Inc. | Chief Executive Officer | Sale+OE | 19,050 | $2.29 | $43,683.90 | -23.3% | +10.9% | -44.3% | |
| Apr 12, 2023 | TXMD Therapeuticsmd, Inc. | Chief Executive Officer | Sale+OE | 1,170 | $3.65 | $4,275.53 | -8.7% | +8.5% | -42.7% | |
| Dec 6, 2022 | TXMD Therapeuticsmd, Inc. | General Counsel | Sale+OE | 1,048 | $4.95 | $5,184.98 | -13.6% | -12.0% | -58.4% | |
| May 11, 2021 | TXMD Therapeuticsmd, Inc. | General Counsel | Sale+OE | 21,592 | $1.04 | $22,455.68 | -42.8% | -8.4% | -93.3% |